2025 third_quarter Filing
Q3Lobbying Activities
Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Issues related to pharmaceutical manufacturing and development.